Northwestern Mutual Wealth Management Co. Boosts Stock Holdings in HCA Healthcare, Inc. $HCA

Key Points

• Northwestern Mutual Wealth Management Co. increased its stake in HCA Healthcare by 61.5% to a total of 13,045 shares, valued at approximately $4.51 million by the end of the most recent quarter.
• HCA Healthcare reported an EPS of $6.84 and revenue of $18.61 billion for the latest quarter, exceeding analysts' estimates and indicating a 6.4% year-over-year revenue growth.
• The company announced a quarterly dividend of $0.72 per share, representing an annualized dividend yield of 0.7%.

Northwestern Mutual Wealth Management Co. boosted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 61.5% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 13,045 shares of the company's stock after acquiring an additional 4,966 shares during the period. Northwestern Mutual Wealth Management Co.'s holdings in HCA Healthcare were worth $4,508,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of HCA. GAMMA Investing LLC lifted its position in HCA Healthcare by 40,527.3% during the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock valued at $5,887,850,000 after purchasing an additional 1,699,713 shares during the last quarter. Nuveen LLC bought a new position in HCA Healthcare during the first quarter valued at $569,217,000. Pacer Advisors Inc. lifted its position in HCA Healthcare by 6,237.9% during the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company's stock valued at $466,815,000 after purchasing an additional 1,329,618 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in HCA Healthcare by 83.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock valued at $829,104,000 after purchasing an additional 1,091,416 shares during the last quarter. Finally, Goldman Sachs Group Inc. lifted its position in HCA Healthcare by 49.1% during the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock valued at $615,583,000 after purchasing an additional 587,036 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Trading Up 0.8%

Shares of HCA opened at $405.18 on Thursday. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. The firm has a market capitalization of $94.81 billion, a price-to-earnings ratio of 17.03, a PEG ratio of 1.26 and a beta of 1.39. The company has a 50-day moving average of $375.76 and a 200 day moving average of $355.47. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company's revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter last year, the firm posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.

Analyst Upgrades and Downgrades

HCA has been the subject of several research reports. Wolfe Research lowered shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research report on Monday, July 28th. Royal Bank Of Canada dropped their price target on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a research note on Monday, July 28th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $444.00 price target on shares of HCA Healthcare in a research note on Tuesday. Truist Financial lifted their price target on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research note on Wednesday, July 16th. Finally, Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have issued a Hold rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $401.83.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.